How the removal of macrophages from tissue can stop or slow down the progression of CLL
CTL019 in pediatric and young adult relapsed/refractory acute lymphoblastic leukemia (ALL) patients
Treatment landscape for elderly acute myeloid leukemia (AML) patients
Are combination therapies more efective for the treatment of relapsed refractory CLL?
ASH 2015 highlights in multiple myeloma by Prof. Ola Landgren